Search Results - "Carta, A.R"

Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model by Carta, A.R, Frau, L, Pisanu, A, Wardas, J, Spiga, S, Carboni, E

“…Abstract Thiazolidinedione (TZD) class of peroxisome proliferator receptor gamma (PPAR-γ) agonists display neuroprotective effects in experimental Parkinson's…”
Get full text

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats by Martinez, A.A, Morgese, M.G, Pisanu, A, Macheda, T, Paquette, M.A, Seillier, A, Cassano, T, Carta, A.R, Giuffrida, A

“…Abstract Long-term administration of l -3,4-dihydroxyphenylalanine (levodopa), the mainstay treatment for Parkinson's disease (PD), is accompanied by…”
Get full text

Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice by Lecca, D, Nevin, D.K, Mulas, G, Casu, M.A, Diana, A, Rossi, D, Sacchetti, G, Carta, A.R

“…Highlights • MDG548 is a novel highly selective PPAR-gamma agonist. • MDG548 is protective against H2 O2 and MPP+ in cultured neurons. • MDG548 inhibits NF-kB…”
Get full text

Corrigendum to “Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice” [Neuroscience 302 (2015) 23–35] by Lecca, D, Nevin, D.K, Mulas, G, Casu, M.A, Diana, A, Rossi, D, Sacchetti, G, Fayne, D, Carta, A.R

Get full text

3.247 MODULATION OF CYTOKINES PRODUCTION AND MICROGLIAL PPAR-GAMMA LEVELS BY ROSIGLIAZONE IN PARKINSON'S DISEASE by Pisanu, A, Spiga, S, Frau, L, Carta, A.R

Get full text

Lack of a role for the D3 receptor in clozapine induction of c-fos demonstrated in D3 dopamine receptor-deficient mice by CARTA, A. R, GERFEN, C. R

“…The role of the D3 dopamine receptor in mediating the effects of clozapine was analysed using in situ hybridization histochemistry to measure the induction of…”
Get full text

Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species by Carta, A.R., Boi, L., Pisanu, A., Palmas, M.F., Carboni, E., De Simone, A.

“…•αSyn oligos/PFFs show structure-related seeding/spreading, neuron and glia toxicity.•AAVαSyn-model: area-specific infusion, face, construct, likely predictive…”
Get full text

Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats by Carta, A.R., Fenu, S., Pala, P., Tronci, E., Morelli, M.

“…The present study investigated long‐term alterations in striatal gene expression after single exposure of unilaterally 6‐hydroxydopamine‐lesioned rats to…”
Get full text

B67 INCREASE IN BASAL GAD67 mRNA EXPRESSION IN THE CENTRAL NUCLEUS OF THE AMYGDALA: A MARKER OF STRESS AND DRUG-INDUCED BEHAVIOURAL SENSITIZATION by Casal, C., Carta, A.R., Cadoni, C., Pirlo, F., Di Chiara, G.

Get full text

A89 CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION WITH POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS by Simola, N., Tronci, E., Cauli, O., Carta, A.R., De Luca, M.A., Morelli, M.

Get full text

Lack of a role for the D 3 receptor in clozapine induction of c-fos demonstrated in D 3 dopamine receptor-deficient mice by Carta, A.R., Gerfen, C.R.

“…The role of the D 3 dopamine receptor in mediating the effects of clozapine was analysed using in situ hybridization histochemistry to measure the induction of…”
Get full text